Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nanomedicine : Nanotechnology, Biology, and Medicine|December 15, 2015
The effects of quercetin-loaded PLGA-TPGS nanoparticles on ultraviolet B-induced skin damages in vivoXianbing Zhu, Xiaowei Zeng, Xudong Zhang, et al.
ACS Nano|February 7, 2018
Intracellular Mechanistic Understanding of 2D MoS<sub>2</sub> Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer TherapyXianbing Zhu, Xiaoyuan Ji, Na Kong, et al.
Molecular Cancer Therapeutics|August 10, 2019
eIF4A Inhibitors Suppress Cell-Cycle Feedback Response and Acquired Resistance to CDK4/6 Inhibition in CancerTim Kong, Yibo Xue, Regina Cencic, et al.
Nature Cell Biology|January 7, 2026
p53 increases phospholipid headgroup scavenging in senescenceJossie J Yashinskie, Xianbing Zhu, Grace H McGregor, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 26, 2018
Two-Dimensional Antimonene-Based Photonic Nanomedicine for Cancer TheranosticsWei Tao, Xiaoyuan Ji, Xianbing Zhu, et al.
Cancer Research|November 15, 2019
CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung CancersTim Kong, Ryuhjin Ahn, Kangning Yang, et al.
The Journal of Pathology|June 20, 2020
SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumorsYibo Xue, Xianbing Zhu, Brian Meehan, et al.
Cancer Research|January 26, 2024
Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in CancerXianbing Zhu, Zheng Fu, Kendall Dutchak, et al.
Nature Communications|May 20, 2023
Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-lossXianbing Zhu, Zheng Fu, Shary Y Chen, et al.
Nature Communications|September 14, 2021
SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca<sup>2+</sup> flux to mitochondriaYibo Xue, Jordan L Morris, Kangning Yang, et al.
Pageof 3